SCHEMBL199623

SCHEMBL199623

Cc1nc2ccc(C(F)(F)F)cn2c1-c1csc(C2(c3ccc(C(=O)NO)cc3)CCOCC2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.37
MCHR1 Q99705 4/20 0.35
PDE2A O00408 2/20 0.35
GABRD O14764 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRA4 P48169 1/20 0.35
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
HDAC1 Q13547 5/20 0.34
HDAC6 Q9UBN7 3/20 0.34
HDAC3 O15379 3/20 0.34
HDAC2 Q92769 3/20 0.34
HDAC7 Q8WUI4 3/20 0.34
HDAC8 Q9BY41 3/20 0.34
HDAC4 P56524 2/20 0.34
HDAC9 Q9UKV0 2/20 0.34
HDAC5 Q9UQL6 2/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
RAF1 P04049 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3350978 0.94 GABRD (0.37) MCHR1GABRDGABRB1GABRA4AKT1
SCHEMBL3352524 0.93 AKT1 (0.38) MCHR1PDE2AGABRDGABRB1GABRA4
SCHEMBL197802 0.89 HDAC1 (0.39) KCNH2GABRDGABRB1GABRA4AKT1
SCHEMBL198164 0.89 KCNH2 (0.38) KCNH2PDE2AAKT1AKT2HDAC1
SCHEMBL196886 0.89 KCNH2 (0.39) KCNH2GABRDGABRB1GABRA4AKT1
SCHEMBL197062 0.88 HDAC1 (0.44) KCNH2GABRDGABRB1GABRA4HDAC1
SCHEMBL197185 0.87 F2RL3 (0.39) KCNH2AKT1AKT2F2RL3
SCHEMBL197443 0.85 CDK2 (0.44) KCNH2HDAC1HDAC6HDAC3HDAC2
SCHEMBL197529 0.84 MKNK1 (0.40) KCNH2AKT1AKT2HDAC1HDAC6
SCHEMBL198898 0.84 F2RL3 (0.37) KCNH2AKT1AKT2HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088771-B2 Cycloalkylidene and heterocycloalkylidene inhibitor compounds GILEAD SCIENCES, INC. (US) 2012-01-03 US claimed
US-20100022543-A1 CYCLOALKYLIDENE AND HETEROCYCLOALKYLIDENE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. 2010-01-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022543-A1 CYCLOALKYLIDENE AND HETEROCYCLOALKYLIDENE INHIBITOR COMPOUNDS HDAC1, HDAC11, HDAC2 KCNH2 4061/4885MCHR1 4699/4885PDE2A 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.